Skip to main content
. 2019 Sep 27;13:1753466619878128. doi: 10.1177/1753466619878128

Table 1.

Background characteristics of COPD patients (n = 1290) and non-COPD participants (n = 199).

General characteristics n COPD (n = 1290) n Non-COPD (n = 199) p-value
Male, n (%) 1290 784 (60.8) 199 102 (51.3) 0.011
Age, years 1290 64.7 ± 9.4 199 63.1 ± 9.4 0.053
Current smoker, n (%) 1232a 380 (30.8) 199 45 (22.6) 0.018
Pack years 194b 40.3 ± 20 133l 16.8 ± 20.6 <0.001
Long term oxygen therapy, n (%) 194c 54 (27.8) - - -
Charlson comorbidity index, points 543d 2 (1–3) 66m 1 (0–2) <0.001
COPD assessment test, points 696e 19 (13–25) - - -
Partner, n (%) 1250f 951 (76.1) 199 169 (84.9) 0.006
Level of education, n (%) 1226g 199 0.585
 Intermediate vocational education or lower 889 (72.5) 148 (74.4)
 Secondary general education or higher 337 (27.5) 51 (25.6)
Working status, n (%) 1237h 198n 0.415
 Paid work 310 (25.1) 55 (27.8)
 No paid work 927 (74.9) 143 (72.2)
Body composition
 BMI (kg/m2) 1290 26 ± 5 199 27.5 ± 4.5 <0.001
  Underweight, n (%) 203 (15.7) 9 (4.5) <0.001
  Normal weight, n (%) 384 (29.8) 58 (29.1)
  Overweight, n (%) 455 (35.3) 82 (41.2)
  Obese, n (%) 248 (19.2) 50 (25.1)
Spirometry
 FEV 1 (% predicted) 1290 55.5 ± 18.9 199 111.5 ± 20.8 <0.001
 FEV 1
(Litres)
1290 1.6 ± 0.6 199 3.1 ± 0.8 <0.001
 FVC (Litres) 1290 3.5 ± 1 199 4 ± 1.1 <0.001
GOLD, n (%) 1290 -
 I 131 (10.2) - -
 II 631 (48.9) - -
 III 430 (33.3) - -
 IV 98 (7.6) - -
Medications in use, nr 194i 7 (5–11) 133o 2 (1–5) <0.001
Dyspnoea
 mMRC, points 744j 2(1–3) -
 <2 mild dyspnoea, n (%) 346 (46.5) - - -
 ⩾2 severe dyspnoea, n (%) 398 (53.5) - -
Fatigue
 CIS-Fatigue, points 1290 35 (26–44) 199 20 (12–28) <0.001
 Normal fatigue, n (%) 329 (25.5) 146 (73.4) <0.001
 Mild fatigue, n (%) 335 (26.0) 33 (16.6)
 Severe fatigue, n (%) 626 (48.5) 20 (10.1)
Exacerbations last 12 months, n 713k 1 (0–2) - - -

Data are shown as mean ± SD, median (IQR) or n(%).

BMI, body mass index; CIS-Fatigue, checklist individual strength subscale fatigue; COPD, chronic obstructive pulmonary disease; FEV1 (% predicted), forced expiratory volume over 1 s of predicted; FVC, forced volume capacity; GOLD, global initiative for chronic obstructive lung disease; IQR, interquartile range; mMRC, modified Medical Research Council dyspnoea scale; SD, standard deviation.

a

58 missing values; b1096 missing values; c1096 missing values; d747 missing values; e594 missing values; f40 missing values; g64 missing values; h53 missing values; i1096 missing values; j546 missing values; k572 missing values; l66 missing values; m133 missing values; n1 missing values; o66 missing values.